Genes underlying such parkinsonian phenotypes may reveal new cellular processes or molecular pathways as potential targets for therapeutic interventions [35] In light of these considerations, we suggest that FIG4 mutations, particularly the I41T mutation, though rare, should be investigated in patients with early-onset parkinsonism and symptoms or signs of unexplained (poly)neuropathy. This evidence concerns the gene FIG4 and Parkinson disease.